Cargando…
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation
Autores principales: | Al-Salameh, Abdallah, Bennis, Youssef, Cariou, Bertrand, Lalau, Jean-Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536836/ https://www.ncbi.nlm.nih.gov/pubmed/34699977 http://dx.doi.org/10.1016/j.diabet.2021.101297 |
Ejemplares similares
-
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
por: Wiernsperger, Nicolas, et al.
Publicado: (2022) -
Association de la metformine au meilleur pronostic chez les patients diabétiques hospitalisés pour la COVID-19 : le bénéfice tiendrait à la continuation de la metformine durant le séjour hospitalier
por: Lalau, Jean-Daniel, et al.
Publicado: (2022) -
La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021) -
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
por: Lalau, Jean-Daniel, et al.
Publicado: (2021) -
Interpreting the Consequences of Metformin Accumulation in an Emergency Context: Impact of the Time Frame on the Blood Metformin Levels
por: Lalau, Jean-Daniel, et al.
Publicado: (2014)